Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Rizzi

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
The Journal of Invasive Cardiology|November 4, 2014
Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) RegistryAndrea Rubboli, Francesco Saia, Alessandro Sciahbasi, et al.
Journal of Medicinal Chemistry|November 27, 2025
Design, Synthesis, and Biological Evaluation of the Novel Neutrophil Elastase Inhibitor CHF-6333 for the Inhaled Treatment of BronchiectasisElisabetta Armani, Andrea Rizzi, Daniela Miglietta, et al.
Journal of Medicinal Chemistry|April 5, 2023
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic DisordersElisabetta Armani, Andrea Rizzi, Nicolò Iotti, et al.
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary FibrosisMarta Giuliani, Andrea Rizzi, Mafalda Pagano, et al.
Journal of Medicinal Chemistry|December 5, 2017
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory DiseasesLaura Carzaniga, Gabriele Amari, Andrea Rizzi, et al.
Journal of Chemical Theory and Computation|September 22, 2021
Development and Benchmarking of Open Force Field v1.0.0-the Parsley Small-Molecule Force FieldYudong Qiu, Daniel G A Smith, Simon Boothroyd, et al.
Journal of Medicinal Chemistry|August 10, 2023
Optimization of M<sub>3</sub> Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPDAndrea Rizzi, Gabriele Amari, Fausto Pivetti, et al.
Journal of Medicinal Chemistry|September 2, 2005
Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretionIlaria Peretto, Stefano Radaelli, Carlo Parini, et al.
Journal of Medicinal Chemistry|June 18, 2021
Discovery of M<sub>3</sub> Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary DiseaseElisabetta Armani, Andrea Rizzi, Carmelida Capaldi, et al.
Journal of Medicinal Chemistry|January 10, 2014
Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseasesElisabetta Armani, Gabriele Amari, Andrea Rizzi, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Invasive Cardiology|November 4, 2014
Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) RegistryAndrea Rubboli, Francesco Saia, Alessandro Sciahbasi, et al.
Journal of Medicinal Chemistry|November 27, 2025
Design, Synthesis, and Biological Evaluation of the Novel Neutrophil Elastase Inhibitor CHF-6333 for the Inhaled Treatment of BronchiectasisElisabetta Armani, Andrea Rizzi, Daniela Miglietta, et al.
Journal of Medicinal Chemistry|April 5, 2023
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic DisordersElisabetta Armani, Andrea Rizzi, Nicolò Iotti, et al.
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary FibrosisMarta Giuliani, Andrea Rizzi, Mafalda Pagano, et al.
Journal of Medicinal Chemistry|December 5, 2017
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory DiseasesLaura Carzaniga, Gabriele Amari, Andrea Rizzi, et al.
Journal of Chemical Theory and Computation|September 22, 2021
Development and Benchmarking of Open Force Field v1.0.0-the Parsley Small-Molecule Force FieldYudong Qiu, Daniel G A Smith, Simon Boothroyd, et al.
Journal of Medicinal Chemistry|August 10, 2023
Optimization of M<sub>3</sub> Antagonist-PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPDAndrea Rizzi, Gabriele Amari, Fausto Pivetti, et al.
Journal of Medicinal Chemistry|September 2, 2005
Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretionIlaria Peretto, Stefano Radaelli, Carlo Parini, et al.
Journal of Medicinal Chemistry|June 18, 2021
Discovery of M<sub>3</sub> Antagonist-PDE4 Inhibitor Dual Pharmacology Molecules for the Treatment of Chronic Obstructive Pulmonary DiseaseElisabetta Armani, Andrea Rizzi, Carmelida Capaldi, et al.
Journal of Medicinal Chemistry|January 10, 2014
Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseasesElisabetta Armani, Gabriele Amari, Andrea Rizzi, et al.
Pageof 11